Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands
- PMID: 27038013
- DOI: 10.1002/ijc.30107
Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands
Abstract
Information on epidemiology is essential to evaluate care for the growing group of oral cancer patients. We investigated trends in incidence, mortality and relative survival rates for oral cavity cancer (OCC) and its subsites in the Netherlands from 1991 to 2010, and relate these to changes in stage and treatment. Patient (age, sex), tumour (subsite, stage) and treatment characteristics of patients diagnosed with OCC (ICD-O-3: C02-C06) in 1991-2010 were extracted from the Netherlands Cancer Registry. Incidence, mortality and 5-year relative survival rates over time are presented, as well as trends in type of treatment. The incidence of OCC increased with +1.2% (95%CI: +0.9%;+1.6%) per year: more strongly in women, stage I and IV disease, and in cancers of the tongue and gum. The mortality rate slightly rose (+0.8%, 95%CI: +0.3%;+1.3% per year), but differed by subsite. The 5-year relative survival improved from 57% in 1991-1995 to 62% in 2006-2010. The 5-year relative survival was better for women compared with men (64% and 55%, respectively), decreased with increasing stage, was the best for tongue cancer (63%) and the worst for cancer of the gum (56%) and floor of mouth cancer (55%). The relative excess risk of dying was higher for non-surgery-based treatments. Surgery was the main treatment option and the proportion of "surgery only" rose in stage I and III disease. The incidence and, to a lesser extent, mortality of OCC are increasing and therefore, even with slightly improving survival rates, OCC is an increasingly important health problem.
Keywords: incidence; mortality; oral cavity cancer; relative survival; treatment.
© 2016 UICC.
Similar articles
-
Gender- and ethnicity-specific survival trends of oral cavity and oropharyngeal cancers in British Columbia.Cancer Causes Control. 2012 Dec;23(12):1899-909. doi: 10.1007/s10552-012-0065-0. Epub 2012 Sep 28. Cancer Causes Control. 2012. PMID: 23053792
-
Second primary cancers in patients with oral cavity cancer included in the Korea Central Cancer Registry.Oral Oncol. 2019 Aug;95:16-28. doi: 10.1016/j.oraloncology.2019.05.025. Epub 2019 Jun 4. Oral Oncol. 2019. PMID: 31345385
-
Oral cavity cancer trends over the past 25 years in Hong Kong: a multidirectional statistical analysis.BMC Oral Health. 2015 Jul 24;15:83. doi: 10.1186/s12903-015-0074-y. BMC Oral Health. 2015. PMID: 26205649 Free PMC article.
-
Oral Cavity Cancer in the Indian Subcontinent - Challenges and Opportunities.Clin Oncol (R Coll Radiol). 2019 Aug;31(8):520-528. doi: 10.1016/j.clon.2019.05.013. Epub 2019 Jun 4. Clin Oncol (R Coll Radiol). 2019. PMID: 31174947 Review.
-
Oral Cavity and Oropharyngeal Cancer Surveillance and Control in Alberta: A Scoping Review.J Can Dent Assoc. 2021 Jan;87:l4. J Can Dent Assoc. 2021. PMID: 34343067
Cited by
-
Clinical efficacy of an antibody-based detection system for human papilloma virus infection in oral squamous cell carcinoma.Clin Oral Investig. 2021 May;25(5):2837-2843. doi: 10.1007/s00784-020-03601-0. Epub 2020 Oct 23. Clin Oral Investig. 2021. PMID: 33098030 Free PMC article.
-
Identification of a novel immune gene panel in tongue squamous cell carcinoma.Am J Transl Res. 2022 May 15;14(5):2801-2824. eCollection 2022. Am J Transl Res. 2022. PMID: 35702068 Free PMC article.
-
Circular RNA hsa_circ_0007059 indicates prognosis and influences malignant behavior via AKT/mTOR in oral squamous cell carcinoma.J Cell Physiol. 2019 Sep;234(9):15156-15166. doi: 10.1002/jcp.28156. Epub 2019 Jan 24. J Cell Physiol. 2019. PMID: 30680715 Free PMC article.
-
Hyperion Image Analysis Depicts a Preliminary Landscape of Tumor Immune Microenvironment in OSCC with Lymph Node Metastasis.J Immunol Res. 2021 Jun 21;2021:9975423. doi: 10.1155/2021/9975423. eCollection 2021. J Immunol Res. 2021. PMID: 34239944 Free PMC article.
-
Hyperion imaging system reveals heterogeneous tumor microenvironment of oral squamous cell carcinoma patients at T1N0M0 stage.Ann Transl Med. 2020 Nov;8(22):1513. doi: 10.21037/atm-20-7194. Ann Transl Med. 2020. PMID: 33313258 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical